Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

298 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Image interpretation criteria for FDG PET/CT in multiple myeloma: a new proposal from an Italian expert panel. IMPeTUs (Italian Myeloma criteria for PET USe).
Nanni C, Zamagni E, Versari A, Chauvie S, Bianchi A, Rensi M, Bellò M, Rambaldi I, Gallamini A, Patriarca F, Gay F, Gamberi B, Cavo M, Fanti S. Nanni C, et al. Eur J Nucl Med Mol Imaging. 2016 Mar;43(3):414-21. doi: 10.1007/s00259-015-3200-9. Epub 2015 Oct 16. Eur J Nucl Med Mol Imaging. 2016. PMID: 26475305
Somatostatin receptor scintigraphy for bronchial carcinoid follow-up.
Fanti S, Farsad M, Battista G, Monetti F, Montini GC, Chiti A, Savelli G, Petrella F, Bini A, Nanni C, Romeo A, Franchi R, Bombardieri E, Canini R, Monetti N. Fanti S, et al. Among authors: nanni c. Clin Nucl Med. 2003 Jul;28(7):548-52. doi: 10.1097/00003072-200307000-00003. Clin Nucl Med. 2003. PMID: 12819406 Clinical Trial.
Role of 18F-FDG PET for evaluating malignant pleural mesothelioma.
Nanni C, Castellucci P, Farsad M, Pinto C, Moretti A, Pettinato C, Marengo M, Boschi S, Franchi R, Martoni A, Monetti N, Fanti S. Nanni C, et al. Cancer Biother Radiopharm. 2004 Apr;19(2):149-54. doi: 10.1089/108497804323071913. Cancer Biother Radiopharm. 2004. PMID: 15186594 Clinical Trial.
Predictive role of positron emission tomography (PET) in the outcome of lymphoma patients.
Zinzani PL, Fanti S, Battista G, Tani M, Castellucci P, Stefoni V, Alinari L, Farsad M, Musuraca G, Gabriele A, Marchi E, Nanni C, Canini R, Monetti N, Baccarani M. Zinzani PL, et al. Among authors: nanni c. Br J Cancer. 2004 Aug 31;91(5):850-4. doi: 10.1038/sj.bjc.6602040. Br J Cancer. 2004. PMID: 15266320 Free PMC article.
18F-FDG PET early after radiotherapy in lymphoma patients.
Castellucci P, Zinzani P, Nanni C, Farsad M, Moretti A, Alinari L, Battista G, Pettinato C, Marengo M, Boschi S, Canini R, Baccarani M, Monetti N, Fanti S. Castellucci P, et al. Among authors: nanni c. Cancer Biother Radiopharm. 2004 Oct;19(5):606-12. doi: 10.1089/cbr.2004.19.606. Cancer Biother Radiopharm. 2004. PMID: 15650453
18F-FDG PET in malignant lymphoma: significance of positive findings.
Castellucci P, Zinzani P, Pourdehnad M, Alinari L, Nanni C, Farsad M, Battista G, Tani M, Stefoni V, Canini R, Monetti N, Rubello D, Alavi A, Franchi R, Fanti S. Castellucci P, et al. Among authors: nanni c. Eur J Nucl Med Mol Imaging. 2005 Jul;32(7):749-56. doi: 10.1007/s00259-004-1748-x. Epub 2005 Mar 23. Eur J Nucl Med Mol Imaging. 2005. PMID: 15785956
Potential pitfalls of 18F-FDG PET in a large series of patients treated for malignant lymphoma: prevalence and scan interpretation.
Castellucci P, Nanni C, Farsad M, Alinari L, Zinzani P, Stefoni V, Battista G, Valentini D, Pettinato C, Marengo M, Boschi S, Canini R, Baccarani M, Monetti N, Franchi R, Rampin L, Fanti S, Rubello D. Castellucci P, et al. Among authors: nanni c. Nucl Med Commun. 2005 Aug;26(8):689-94. doi: 10.1097/01.mnm.0000171781.11027.bb. Nucl Med Commun. 2005. PMID: 16000986
298 results